AFP and cholangiocarcinoma: WAKIZAKA K et al believed that the laboratory and imaging features of CCA were: elevated serum CA199, insignificant elevation of AFP, no previous history of hepatitis B, a low-density mass in the liver by CT, ring enhancement in the arterial phase, and heterogeneous enhancement of the tumor in the delayed phase.